Northstar Asset Management Inc. Has $7.48 Million Stake in Danaher Co. (NYSE:DHR)

Northstar Asset Management Inc. lowered its stake in Danaher Co. (NYSE:DHR) by 6.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 32,581 shares of the conglomerate’s stock after selling 2,073 shares during the period. Danaher accounts for 2.0% of Northstar Asset Management Inc.’s portfolio, making the stock its 25th largest position. Northstar Asset Management Inc.’s holdings in Danaher were worth $7,479,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently bought and sold shares of DHR. D.A. Davidson & CO. raised its position in shares of Danaher by 11.6% during the fourth quarter. D.A. Davidson & CO. now owns 14,835 shares of the conglomerate’s stock worth $3,405,000 after acquiring an additional 1,541 shares during the last quarter. CIBC Asset Management Inc increased its position in Danaher by 24.4% in the fourth quarter. CIBC Asset Management Inc now owns 254,327 shares of the conglomerate’s stock worth $58,308,000 after purchasing an additional 49,964 shares during the period. Pittenger & Anderson Inc. raised its holdings in Danaher by 0.7% during the 4th quarter. Pittenger & Anderson Inc. now owns 68,298 shares of the conglomerate’s stock worth $15,678,000 after purchasing an additional 475 shares during the last quarter. AlphaCentric Advisors LLC acquired a new position in Danaher during the 4th quarter valued at about $958,000. Finally, Nicholas Hoffman & Company LLC. boosted its stake in shares of Danaher by 4.6% in the 4th quarter. Nicholas Hoffman & Company LLC. now owns 1,951 shares of the conglomerate’s stock valued at $448,000 after purchasing an additional 85 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 11.10% of the stock is owned by company insiders.

Danaher Stock Up 1.5 %

NYSE:DHR opened at $206.66 on Tuesday. The company has a market cap of $149.26 billion, a PE ratio of 39.14, a PEG ratio of 2.68 and a beta of 0.83. The stock has a 50-day simple moving average of $229.53 and a 200 day simple moving average of $249.13. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the firm earned $2.09 EPS. On average, sell-side analysts expect that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were issued a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.52%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on DHR shares. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Stifel Nicolaus increased their price target on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Guggenheim assumed coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price objective for the company. Royal Bank of Canada restated an “outperform” rating and set a $277.00 target price (down previously from $299.00) on shares of Danaher in a report on Thursday, January 30th. Finally, UBS Group lowered their price target on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Seven equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.